Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase NA 2Phase 2 1Phase 1/2 1

Status

Completed 24Active not recruiting 3Terminated 2Recruiting 1

Sponsor Class

INDUSTRY 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 2Thoracic 1Plasma cell 1Lymphoid 1Head & Neck 1Gynecologic 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 102Breast Neoplasms 79Neoplasms 72Melanoma 63Neoplasm Metastasis 62Leukemia, Myeloid, Acute 58Ovarian Neoplasms 54Lymphoma, Non-Hodgkin 53Multiple Myeloma 51Colorectal Neoplasms 50Prostatic Neoplasms 49Glioblastoma 48Pancreatic Neoplasms 47Lung Neoplasms 45Recurrence 42Carcinoma, Renal Cell 40Leukemia, Lymphocytic, Chronic, B-Cell 37Squamous Cell Carcinoma of Head and Neck 36Triple Negative Breast Neoplasms 34Myelodysplastic Syndromes 30Lymphoma, Large B-Cell, Diffuse 28Glioma 28Stomach Neoplasms 27Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Lymphoma, B-Cell 27Brain Neoplasms 27Lymphoma, Follicular 26Endometrial Neoplasms 26Lymphoma 25Carcinoma, Hepatocellular 24

Interventions

veliparib 1belantamab mafodotin 1Taxes 1Paclitaxel 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Active not recruiting × Renal Insufficiency × Clear all
NCT07154901 2026-05-22

Investigation of the Effects of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of Opemalirsen (AZD2373)

AstraZeneca

Phase 1 Active not recruiting
34 enrolled
Lymphoid

Lymphoma, Follicular, Renal Insufficiency

NCT01366144 2026-04-13

Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction

National Cancer Institute (NCI)

Phase 1 Active not recruiting
94 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Breast Neoplasms, Carcinoma, Transitional Cell, Esophageal Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Neoplasms, Unknown Primary, Ovarian Neoplasms, Testicular Neoplasms, Endometrial Neoplasms, Liver Failure, Renal Insufficiency

NCT04398745 2025-05-23

DREAMM12

GlaxoSmithKline

Phase 1 Active not recruiting
36 enrolled
GenitourinaryPlasma cell

Kidney Failure, Chronic, Multiple Myeloma, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡